Revisiting oral fluoropyrimidine with cetuximab in metastatic colorectal cancer: Real-world data in Chinese population

Table 4 Cox regression analysis for the effects of different predictors on progression-free survival

Factor	Crude HR (95%CI)	Adjusted HR (95%CI)	P value1
Age	1.00 (0.98-1.02)	1.00 (0.98-1.02)	0.909
Male	0.91 (0.60-1.38)	1.00 (0.64-1.54)	0.985
Right sided primary	1.63 (0.97-2.74)	1.87 (1.08-3.25)	a0.026
Primary resected	0.39 (0.24-0.63)	0.35 (0.21-0.59)	b<0.001
Liver only disease	0.56 (0.37-0.86)	0.57 (0.36-0.91)	c0.019
Infusional FP2	0.92 (0.60-1.42)	1.00 (0.63-1.57)	0.992

¹It refers to the P-values for multivariable Cox regression analysis (i.e., adjusted HR);

²FP refers to fluoropyrimidine.

^aP: Right sided primary;

^bP: Primary resected;

^cP: Liver-only disease.